首页> 美国卫生研究院文献>In Vivo >Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Versus Cryoablation for T1 Renal Cell Carcinoma
【2h】

Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Versus Cryoablation for T1 Renal Cell Carcinoma

机译:用于T1肾细胞癌的机器人辅助部分肾切除术的治疗和临床结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: In cT1 renal cell carcinoma (RCC), very few studies have compared oncological outcomes and renal function preservation rates in nephron-sparing robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA). Patients and Methods: We retrospectively analysed 126 patients with cT1 RCC treated with RAPN (n=78) and computed tomography-guided PCA (n=48) between March 2016 and November 2019. Clinical data and outcomes were compared for the two groups. Results: There were no significant differences in the 3-year overall survival and relapse-free survival rates in the two groups (p=0.17 and p=0.093, respectively). The median percentage of estimated glomerular filtration rate preservation at 6 months after surgery was 91.8% and 91.4% in the RAPN and PCA groups, respectively (p=0.9). Conclusion: In patients with cT1a RCC, oncological outcomes and renal function appear similar following RAPN and PCA.
机译:背景:在CT1肾细胞癌(RCC)中,很少有研究使肾脏备杂机器人辅助部分肾切除术(RAPN)和经皮和经皮和经皮(PCA)进行了比较了阳性结果和肾功能保存率。患者及方法:我们回顾性分析了126例CT1 RCC患者,在2016年3月和2019年11月间使用RAPN(N = 78)和计算机断层扫描引导PCA(n = 48)。比较两组的临床资料和结果。结果:两组的3年整体存活率和无复发存活率没有显着差异(P = 0.17和P = 0.093)。手术后6个月的估计肾小球过滤速率保存的中位数分别为RAPN和PCA组的91.8%和91.4%(P = 0.9)。结论:在RAPN和PCA患有CT1A RCC的患者中,肿瘤性结果和肾功能似乎类似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号